These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 21572027)

  • 1. B Lymphocyte commitment program is driven by the proto-oncogene c-Myc.
    Vallespinós M; Fernández D; Rodríguez L; Alvaro-Blanco J; Baena E; Ortiz M; Dukovska D; Martínez D; Rojas A; Campanero MR; Moreno de Alborán I
    J Immunol; 2011 Jun; 186(12):6726-36. PubMed ID: 21572027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Coordinate regulation of B cell differentiation by the transcription factors EBF and E2A.
    O'Riordan M; Grosschedl R
    Immunity; 1999 Jul; 11(1):21-31. PubMed ID: 10435576
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The proto-oncogene c-myc regulates antibody secretion and Ig class switch recombination.
    Fernández D; Ortiz M; Rodríguez L; García A; Martinez D; Moreno de Alborán I
    J Immunol; 2013 Jun; 190(12):6135-44. PubMed ID: 23690468
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Roles of EBF and Pax-5 in B lineage commitment and development.
    Maier H; Hagman J
    Semin Immunol; 2002 Dec; 14(6):415-22. PubMed ID: 12457614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assembling a gene regulatory network for specification of the B cell fate.
    Medina KL; Pongubala JM; Reddy KL; Lancki DW; Dekoter R; Kieslinger M; Grosschedl R; Singh H
    Dev Cell; 2004 Oct; 7(4):607-17. PubMed ID: 15469848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transcription factor EBF restricts alternative lineage options and promotes B cell fate commitment independently of Pax5.
    Pongubala JM; Northrup DL; Lancki DW; Medina KL; Treiber T; Bertolino E; Thomas M; Grosschedl R; Allman D; Singh H
    Nat Immunol; 2008 Feb; 9(2):203-15. PubMed ID: 18176567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined heterozygous loss of Ebf1 and Pax5 allows for T-lineage conversion of B cell progenitors.
    Ungerbäck J; Åhsberg J; Strid T; Somasundaram R; Sigvardsson M
    J Exp Med; 2015 Jun; 212(7):1109-23. PubMed ID: 26056231
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pax5--a critical inhibitor of plasma cell fate.
    Nera KP; Lassila O
    Scand J Immunol; 2006 Sep; 64(3):190-9. PubMed ID: 16918686
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early B cell factor is an activator of the B lymphoid kinase promoter in early B cell development.
    Akerblad P; Sigvardsson M
    J Immunol; 1999 Nov; 163(10):5453-61. PubMed ID: 10553071
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD19 is a major B cell receptor-independent activator of MYC-driven B-lymphomagenesis.
    Chung EY; Psathas JN; Yu D; Li Y; Weiss MJ; Thomas-Tikhonenko A
    J Clin Invest; 2012 Jun; 122(6):2257-66. PubMed ID: 22546857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. EBF1 and Pax5 safeguard leukemic transformation by limiting IL-7 signaling, Myc expression, and folate metabolism.
    Ramamoorthy S; Kometani K; Herman JS; Bayer M; Boller S; Edwards-Hicks J; Ramachandran H; Li R; Klein-Geltink R; Pearce EL; Grün D; Grosschedl R
    Genes Dev; 2020 Nov; 34(21-22):1503-1519. PubMed ID: 33004416
    [No Abstract]   [Full Text] [Related]  

  • 12. EBF1, PAX5, and MYC: regulation on B cell development and association with hematologic neoplasms.
    Li L; Zhang D; Cao X
    Front Immunol; 2024; 15():1320689. PubMed ID: 38318177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early B cell factor promotes B lymphopoiesis with reduced interleukin 7 responsiveness in the absence of E2A.
    Seet CS; Brumbaugh RL; Kee BL
    J Exp Med; 2004 Jun; 199(12):1689-700. PubMed ID: 15210745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. c-Myc activation by Theileria parasites promotes survival of infected B-lymphocytes.
    Dessauge F; Hilaly S; Baumgartner M; Blumen B; Werling D; Langsley G
    Oncogene; 2005 Feb; 24(6):1075-83. PubMed ID: 15580287
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EBF1 and PAX5 control pro-B cell expansion via opposing regulation of the Myc gene.
    Somasundaram R; Jensen CT; Tingvall-Gustafsson J; Åhsberg J; Okuyama K; Prasad M; Hagman JR; Wang X; Soneji S; Strid T; Ungerbäck J; Sigvardsson M
    Blood; 2021 Jun; 137(22):3037-3049. PubMed ID: 33619557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamic regulation of c-Myc proto-oncogene expression during lymphocyte development revealed by a GFP-c-Myc knock-in mouse.
    Huang CY; Bredemeyer AL; Walker LM; Bassing CH; Sleckman BP
    Eur J Immunol; 2008 Feb; 38(2):342-9. PubMed ID: 18196519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pax5 maintains cellular identity by repressing gene expression throughout B cell differentiation.
    Carotta S; Holmes ML; Pridans C; Nutt SL
    Cell Cycle; 2006 Nov; 5(21):2452-6. PubMed ID: 17102626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Loss of Pax5 promotes plasma cell differentiation.
    Nera KP; Kohonen P; Narvi E; Peippo A; Mustonen L; Terho P; Koskela K; Buerstedde JM; Lassila O
    Immunity; 2006 Mar; 24(3):283-93. PubMed ID: 16546097
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The chromatin remodeler Brg1 activates enhancer repertoires to establish B cell identity and modulate cell growth.
    Bossen C; Murre CS; Chang AN; Mansson R; Rodewald HR; Murre C
    Nat Immunol; 2015 Jul; 16(7):775-84. PubMed ID: 25985234
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the proto-oncogene c-myc in B lymphocyte differentiation.
    Fernandez D; Sanchez-Arevalo VJ; de Alboran IM
    Crit Rev Immunol; 2012; 32(4):321-34. PubMed ID: 23237508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.